APUSApimeds Pharmaceuticals US Inc. Common Stock

AMEX · US · Healthcare · Drug Manufacturers - Specialty & Generic · mindwavedao.com

4.840USD+10.25%Mkt Cap: 7.30M $P/E: —3d ago

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. op…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap7.30M $

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-6.00M $

Revenue/Share—

Last Price4.840 USD

Fiscal Year End—

MR Quarter—

Employees—

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B7.46

EPS (TTM)-35.98

EPS (Forward)—

52W Range

3.3900% of range403.10

52W High403.10 USD

52W Low3.390 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-3.91%

ROA-3.66%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-8.93M $

CapEx (TTM)57.33K $

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.05

Current Ratio—

Quick Ratio—

Book Value/Sh0.6490 USD

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateJul 24, 2026

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.51M

Float—

Insiders58.70%

Institutions2.83%

Short Interest

Short Ratio0.7d

Short % Float3.33%

Short % Out.1.78%

Shares Short26.81K

Short (prev mo.)23.12K

Technical

SMA 507.161 (-32.4%)

SMA 20015.33 (-68.4%)

Beta—

S&P 52W Chg19.18%

Avg Vol (30d)110.99K

Avg Vol (10d)265.37K

Technical Indicators

RSI (14)42.1

MACD-0.8651

MACD Signal-1.0690

MACD Hist.+0.2038

BB Upper6.708 USD

BB Middle4.913 USD

BB Lower3.119 USD

BB Width73.03%

ATR (14)0.9258 USD

Vol Ratio (20d)4.12x